About
Erik Woods is a cell therapy and cryopreservation executive best known as co-founder, Chief Science Officer, and EVP of Ossium Health, a clinical-stage bioengineering company focused on organ-donor-derived bone marrow and related cell therapies. Before Ossium, he co-founded and led General BioTechnology until its assets were acquired by Cook Group in 2012, later serving as Senior VP of COOK Regentec. He is also a Fellow and former President of the Society for Cryobiology.
Areas of interest
longevitybiotechcell therapycryopreservationstem cell bankingbone marrow bankingregenerative medicineorthopedicsclinical laboratory operations